Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-11-29Clinical Trial Update: Inflammatory Markers in Exhaled Breath (Condensate) in Childhood Asthma
Completed clinical trial assessing inflammatory markers in exhaled breath condensate from children with asthma and comparing with healthy co…
-
CLINICAL_TRIALS trial_result · 2006-11-28Clinical Trial Update: Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids [Phase 4]
Phase 4 trial update evaluating the combination of systemic steroids and inhaled steroids for treating acute asthma exacerbations in the eme…
-
CLINICAL_TRIALS trial_result · 2006-11-22Clinical Trial Update: The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry [NA]
A completed clinical trial comparing the anti-inflammatory effects of extrafine HFA-beclometasone versus HFA-fluticasone in asthma using inf…
-
FDA approval · 2006-11-20FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Pulmicort Respu les (budesonide) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2006-11-07Clinical Trial Update: Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma [NA]
Clinical trial evaluating the effect of omalizumab (Xolair) in patients with aspirin-exacerbated respiratory disease and allergic asthma; cu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-10-25FDA Approved: FLUTICASONE PROPIONATE HFA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Fluticasone Propionate HFA submitted by Prasco Laboratories under NDA 021433.
-
CLINICAL_TRIALS research · 2006-10-18Clinical Trial Update: Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 [Phase 2, Phase 3]
Clinical trial update on using probiotic bacteria to prevent allergic diseases in children, spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS research · 2006-10-12Clinical Trial Update: Development of a Breath Analyzer for Asthma Screening
The document reports on the development of a breath analyzer for asthma screening and provides an update on the related clinical trial; the …
-
CLINICAL_TRIALS trial_result · 2006-10-09Clinical Trial Update: A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control [Phase 4]
A Phase 4 pilot efficacy trial evaluating inhaled albuterol delivered with the Akita Breath Control device for asthma.
-
CLINICAL_TRIALS trial_result · 2006-10-03Clinical Trial Update: Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus in Children With Asthma [Phase 3]
A phase 3 trial comparing CAIV-T (live attenuated influenza vaccine) with an influenza vaccine in children with asthma has completed.
-
FDA approval · 2006-09-15FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate). The approval relates to changes descri…
-
CLINICAL_TRIALS research · 2006-09-04Clinical Trial Update: Outdoor Allergen Exposure, Sensitivity, and Acute Asthma
A completed NIEHS-sponsored clinical trial investigates how outdoor allergen exposure affects sensitivity and acute asthma.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Magnesium and Asthma - Clinical Trials [Phase 2]
A Phase 2 clinical trial evaluating magnesium for asthma has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Borage Oil and Ginkgo Biloba (EGb 761) in Asthma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating borage oil and Ginkgo biloba EGb 761 for asthma has completed.
-
FDA approval · 2006-07-21FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved the original application for budesonide and formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP, a co…
-
FDA approval · 2006-07-21FDA Approved: PULMICORT RESPULES — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Pulmicort Respules (budesonide) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2006-07-12FDA Approved: PULMICORT FLEXHALER — Original Application (H2-Pharma LLC)
FDA approved Pulmicort Flexhaler (budesonide) through an Original Application (NDA021949) by H2-Pharma LLC.
-
CLINICAL_TRIALS research · 2006-07-10Clinical Trial Update: Impact of Asthma Treatments on Daily Activities
This document provides an update on a clinical trial evaluating the impact of asthma treatments on daily activities.
-
CLINICAL_TRIALS trial_result · 2006-06-28Clinical Trial Update: Effect of an Integrated Care Pathway on Asthma Care in Hospital [NA]
A completed clinical trial evaluating whether implementing an integrated care pathway improves asthma care in hospital settings. The study a…
-
FDA approval · 2006-06-08FDA Approved: ADVAIR HFA — Original Application (GlaxoSmithKline LLC)
This document records the original FDA approval of Advair HFA, a combination inhaled therapy of fluticasone propionate and salmeterol xinafo…
-
FDA approval · 2006-05-19FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) by Organon LLC, resulting in labeling modifications related to its indic…
-
FDA approval · 2006-05-19FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2006-05-04Clinical Trial Update: TNF Alpha in Refractory Asthma [NA]
The study evaluating TNF-alpha targeting therapy for refractory asthma has completed; no specific results are described in the update.